Skip to Main Content
 
Funding Opportunities

Standard Due Dates for NIH Competing Applications

Open Deadlines    

NIH Parent Announcements PA-20-185 (R01), PA-20-200 (R03), PA-20-195 (R21)
NIH success rates by grant mechanism and Institute/Center
NIH Center for Scientific Review study section information
DOD FY23-FY27 Broad Agency Announcement for Extramural Medical Research


       February   2019       
Sun Mon Tue Wed Thr Fri Sat  
27 28 29 30 31 1

Natl Marfan Fdn

NIH

CRI

FRAXA

NSF

Bayer

NIH

Mathew Larson Pediatric Brain Tumor Fdn

CureSearch for Children's Cancer

CureSearch for Children's Cancer

JCC

NSF

ALR

DRCRF

Natl Marfan Fdn

L’Oréal

PhRMA

Sjögren’s Syndrome Fdn

NIH
2
3 4

NIH

NIH

Cooley's Anemia Fdn

NIH

NIH/NIMH
5

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH
6

BWF
7

AHA
8

Natl Kidney Fdn

NIH

NIH

AACR

NIH

NIH
9
10 11

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH
12

Tourette Syndrome Assn

NSF

NIH

NIH

NIH

NIH

NIH

NIH

NIH

NIH
13

Autism

DOD

Int'l Waldenstrom's Macroglobulinemia Fdn

NIH

NIH
14

Fondation Leducq

NSF

Klarman Family Fdn
15

LLS

Klingenstein

NIH

NIH

NSF

Dannon
16

NIH

NIH

NIH
17 18

Mark Fdn for Cancer Research
19 20

NSF

NSF

NIH
21

NIH

NIH

NIH
22

Simons Fdn

NIH

DOD
23
24 25

Bladder Cancer Advocacy Network
26

NSF

NIH

NIH

NIH

NIH

NIH

NIH
27

NIH

NIH

NIH

NIH
28

NSF

NIH

NIH

Intl OCD Fdn

NSF

NIH

DHHS
1 2